New antibody-chemo combo shows promise for mesothelioma
NCT ID NCT05918107
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called PM8002, which targets two proteins that help cancer grow, combined with standard chemotherapy. It involved 31 adults with a rare cancer called malignant mesothelioma that could not be removed by surgery. The goal was to see if the combination shrinks tumors and is safe, but it is not a cure—patients may need ongoing treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
-
Chinese PLA General Hospital
Beijing, China
-
Chongqing University Cancer Hospital
Chongqing, China
-
Fujian Cancer Hospital
Fuzhou, China
-
Harbin Medical University Cancer Hospital
Harbin, China
-
Henan Cancer Hospital
Zhengzhou, China
-
Jiangsu Province Hospital
Nanjing, China
-
Jilin Provincial Tumor Hospital
Changchun, China
-
Liaoning Cancer Hospital and Institute
Dalian, China
-
Peking Cancer Hospital
Beijing, China
-
Shandong Cancer Hospital
Jinan, China
-
Shanghai Pulmonary Hospital
Shanghai, China
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
-
The First Hospital of Hebei Medical University
Shijiazhuang, China
-
Zhejiang Cancer Hospital
Hangzhou, China
-
Zhejiang Provincial People's Hospital
Hangzhou, China